Texture Features and Pharmacokinetic Parameters in Differentiating Benign and Malignant Breast Lesions by Dynamic Contrast Enhanced Magnetic Resonance Imaging

Oncology Letters - Greece
doi 10.3892/ol.2018.9196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Pharmacokinetic Models in Prostate Cancer

European Radiology
MedicineNuclear MedicineRadiologyImaging
2010English

Diagnostic Investigation of Breast Magnetic Resonance Imaging in Malignant and Benign Mass Lesions

Archives of Medical Science
Medicine
2018English

Contrast Agents in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Oncotarget
Oncology
2017English

Value of Diffusion-Weighted Imaging in Differentiating Benign From Malignant Breast Lesions

Breast Cancer Research
Cancer ResearchOncology
2009English

Assessment of the Dynamic Range in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Breast Examinations

Breast Cancer Research
Cancer ResearchOncology
2012English

Role of Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Differentiating Post Therapeutic Changes From Recurrent Malignant Breast Lesions

The Medical Journal of Cairo University
2019English

Techniques and Applications of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Cancer

2014English

Pharmacokinetic Analysis for the Differentiation of Pituitary Microadenoma Subtypes Through Dynamic Contrast‑enhanced Magnetic Resonance Imaging

Oncology Letters
Cancer ResearchOncology
2019English

Imaging Tumor Vascular Heterogeneity and Angiogenesis Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Clinical Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy